South State Corp Biogen Inc. Transaction History

South State Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $1,767 - $2,147	7 Added 18.42%	45 $12,000
Q1 2022 May 06, 2022	SELL	$193.77 - $244.14 $2,712 - $3,417	-14 Reduced 26.92%	38 $8,000
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $11,319 - $14,762	-40 Reduced 43.48%	52 $15,000
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $23,828 - $38,153	92 New	92 $32,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $238,799 - $337,741	-918 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $112,903 - $126,460	-367 Reduced 28.56%	918 $292,000
Q3 2017 Nov 09, 2017	SELL	$281.15 - $329.69 $33,738 - $39,562	-120 Reduced 8.54%	1,285 $403,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,405	1,405 $382,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

Stay updated on South State Corp with notifications on news.